Thus, T4 has substantial potential for clinical translation as a multiple-target therapy for MS/EAE or other neurological demyelinating diseases, with the remyelination effect supplementing its anti-inflammatory and neuroprotective role, as previously found in studies involving T4 prophylactic treatment (Zhang et al., 2009)
10.1016/j.bmcl.2020.127716 138 ZhouC.WangY.ZhangQ.ZhouG.MaX.JiangX.et al (2023)
GLP-1 patches represent a newer option that provides transdermal delivery, though evidence for their effectiveness compared to injections is still limited
What We Still Dont Know: Virtually no large, controlled human trials most data comes from animal models and posts like this, anecdotal
Anakinra, as a recombinant IL-1 receptor antagonist, can block the biological activity of IL-1 and IL-1, thereby inhibiting the inflammatory cascade (Szabo et al., 2022)
[20] [1] Patients should be advised to contact their GP if they experience persistent vomiting, signs of dehydration, severe abdominal pain, or symptoms of hypoglycaemia (sweating, tremor, confusion, palpitations)
